Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:31610510 | IVTH | 0.00000625 M | 0.00000625 M | Decrease in corticosterone levels | Neurological endocrine-mediated perturbations |
IVTH | 0.00000625 M | 0.00000625 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000625 M | 0.00000625 M | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000625 M | 0.00000625 M | Decrease in cortisol levels | Neurological endocrine-mediated perturbations | |
IVTH | 0.00000625 M | 0.00000625 M | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000625 M | 0.00000625 M | Decreased pregnenolone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000625 M | 0.00000625 M | Increased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000625 M | 0.00000625 M | Increased estrone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000178 M | 0.00000178 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000178 M | 0.00000178 M | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000178 M | 0.00000178 M | Decreased pregnenolone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000178 M | 0.00000178 M | Decrease in cortisol levels | Neurological endocrine-mediated perturbations | |
IVTH | 0.00000178 M | 0.00000178 M | Increased estrone levels | Reproductive endocrine-mediated perturbations | |
IVR | 450 mg/kg/day | 450 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Decreased androstenedione levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Decrease in cortisol levels | Neurological endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Decreased estrone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Decreased pregnenolone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Decrease in corticosterone levels | Neurological endocrine-mediated perturbations | |
IVR | 150 mg/kg/day | 150 mg/kg/day | Affects anogenital distance in offspring | Developmental | |
IVTH | 0.00005 M | 0.00005 M | Decreased testosterone levels | ||
IVTH | 0.0000125 M | 0.0000125 M | Affects steroid metabolism | ||
IVTH | 0.0000125 M | 0.0000125 M | Increased estrone levels | ||
IVTH | 0.0000125 M | 0.0000125 M | Increased estradiol levels | ||
IVTH | 0.0000125 M | 0.0000125 M | Increased testosterone levels | ||
IVTH | 0.0000125 M | 0.0000125 M | Decreased pregnenolone levels | ||
IVTH | 0.0000125 M | 0.0000125 M | Decrease in cortisol levels | ||
IVTH | 0.0000125 M | 0.0000125 M | Decrease in corticosterone levels | ||
IVTH | 0.00000313 M | 0.00000313 M | Increased testosterone levels | ||
IVTH | 0.00000313 M | 0.00000313 M | Increased estrone levels | ||
IVTH | 0.00000313 M | 0.00000313 M | Decreased pregnenolone levels | ||
IVTH | 0.00000313 M | 0.00000313 M | Affects steroid metabolism | ||
IVTH | 0.00000313 M | 0.00000313 M | Decreased progesterone levels | ||
IVTH | 0.00000313 M | 0.00000313 M | Increased estradiol l | ||
IVTH | 0.00000313 M | 0.00000313 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.000025 M | 0.000025 M | |||
IVTH | 0.00000078 M | 0.00000078 M | |||
IVTH | 0.00000078 M | 0.00000078 M | |||
IVTH | 0.00000078 M | 0.00000078 M | |||
IVTH | 0.00000078 M | 0.00000078 M |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.